BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38006567)

  • 21. Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers.
    Sun Q; Fu Y; Chen X; Li L; Wu H; Liu Y; Xu H; Zhou G; Fan X; Xia H
    Gut Liver; 2022 Nov; 16(6):875-891. PubMed ID: 35611665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
    Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
    PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
    Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
    Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation].
    Yang Y; Liu YQ; Wang XH; Ji K; Li ZW; Bai J; Yang AR; Hu Y; Han HB; Li ZY; Bu ZD; Wu XJ; Zhang LH; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):451-458. PubMed ID: 31209416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Landscape of Epstein-Barr Virus-Associated Gastric Cancer: Analysis From a Western Academic Institution.
    Yee EJ; Gilbert D; Kaplan J; van Dyk L; Kim SS; Berg L; Clambey E; Wani S; McCarter MD; Stewart CL
    J Surg Res; 2024 Apr; 296():742-750. PubMed ID: 38368775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
    Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
    PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer.
    Sarshari B; Ravanshad M; Rabbani A; Zareh-Khoshchehreh R; Mokhtari F; Khanabadi B; Mohebbi SR; Asadzadeh Aghdaei H
    Virus Genes; 2023 Jun; 59(3):351-358. PubMed ID: 36757510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
    Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
    Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
    Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
    Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
    Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
    Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
    Chen JN; He D; Tang F; Shao CK
    J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of a distinctive strain of Epstein-Barr virus with gastric cancer.
    Corvalan A; Ding S; Koriyama C; Carrascal E; Carrasquilla G; Backhouse C; Urzua L; Argandoña J; Palma M; Eizuru Y; Akiba S
    Int J Cancer; 2006 Apr; 118(7):1736-42. PubMed ID: 16217758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune checkpoint inhibitors are effective in the treatment of Epstein-Barr virus-associated gastric cancer: A case report.
    An G; He XC; Bai J; Wang J
    Medicine (Baltimore); 2023 Mar; 102(13):e33377. PubMed ID: 37000076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
    Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
    Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
    Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
    J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Yang J; Liu Z; Zeng B; Hu G; Gan R
    Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
    Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
    Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
    Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
    J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic Characteristics of Epstein-Barr Virus-Associated Gastric Cancer Over the Past Decade in Japan.
    Yanagi A; Nishikawa J; Shimokuri K; Shuto T; Takagi T; Takagi F; Kobayashi Y; Yamamoto M; Miura O; Yanai H; Suehiro Y; Yamasaki T; Yoshiyama H; Sakaida I
    Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31480554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.